Bone metastasis detected by FDG PET in a patient with breast cancer and fibrous dysplasia

Clinical Nuclear Medicine

Volumn 30, Issue 8, 2005, Pages 571-573

  Shigesawa, Toshirou ^a   Sugawara, Yoshifumi ^b   Shinohara, Isao ^a   Fujii, Takashi ^b   Mochizuki, Teruhito ^b   Morishige, Ichiro ^a  

^a N   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone metastasis; Bone scan; Breast cancer; FDG PET; Fibrous dysplasia

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; TUMOR MARKER;

ADULT; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER RADIOTHERAPY; CASE REPORT; FEMALE; FIBROUS DYSPLASIA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

BONE NEOPLASMS; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, DUCTAL, BREAST; FEMALE; FIBROCYSTIC BREAST DISEASE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; RADIOPHARMACEUTICALS; WHOLE-BODY COUNTING;

EID: 22644439559     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000170058.73956.82     Document Type: Article

References (6)

1. Johns WD, Gupta SM, Kayani N. Scintigraphic evaluation of polyostotic fibrous dysplasia. Clin Nucl Med. 1987;12:627-631.
2. Toba M, Hayashida K, Imakita S, et al. Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia. Ann Nucl Med. 1998;12:153-155.
3. Tanabeu Y, Nakahara S, Mitsuyama S, Ono M, Toyoshima S. Breast cancer in a patient with McCune-Albright syndrome. Breast Cancer. 1998;5:175-178.
4. Ohta M, Tokuda Y, Suzuki Y, et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun. 2001;22:875-879.
5. Peterson JJ, Kransdorf MJ, O'Connor MI. Diagnosis of occult bone metastases: positron emission tomography. Clin Orthop S. 2003:120-128.
6. van der Hoeven JJ, Krak NC, Hoekstra OS, et al. 18F-2-fluoro-2-deoxy-d- glucose positron emission tomography in staging of locally advanced breast cancer. J Clin Oncol. 2004;22:1253-1259.